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SUMMARY
Open access endoscopy (OAE) is widely used in many hospitals. The aim of this study was to
compare the upper gastrointestinal endoscopies referred to as "OGDs" performed under the
OAE service and those referred from hospital outpatient clinics (HR) during the initial year in
which an OAE service was provided in a district general hospital.
AretrospectivereviewofmedicalrecordsfromallpatientsundergoingOGDduringthefirstyear
ofOAE toidentifythe waiting time forOGD, the extentofpre-treatment atthe time ofOGD, the
endoscopicfindingsandthenumberofendoscopiesinwhichoesophagealorgastricneoplasiawas
detected. Follow-up endoscopies (n=41) were excluded.
Of 739 OGDs included, 384 (177 male; mean age 48.0 yrs.) were performed under the OAE
service, 346 (149 male; mean age 50.7 yrs.) were referred from outpatient clinics and 9 could not
be accuratelyclassified. The waiting time wassignificantly lowerin the OAE group compared to
the HR group (24.5 v 29.8 days, p<0.001). Pre-treatment at the time of OGD was significantly
morefrequent in the OAE group compared to the HR group (295 v 186,p<0.001). Frequencies of
the main endoscopic diagnoses did not differ significantly between the two groups.
The OAE service provided faster access to OGD than the HR group and the endoscopic findings
were similar in the two groups.
INTRODUCTION
Since it is generally accepted that the clinical
evaluation of dyspepsia will misclassify one-
third of major pathological lesions, upper
gastrointestinal endoscopy (OGD) is necessary
todeterminethespecificaetiologyandtoidentify
the most appropriate therapy, at least in patients
over45yearsold.1 Openaccessendoscopyallows
rapid access to outpatient OGD for patients in
primary care. A recent British Society of
Gastroenterology survey reported that 74% of
members were offering this service.2 It has been
suggestedthatanopenaccess servicewillprovide
a shorter waiting time for endoscopy in
comparison to those who have an initial
consultationattheoutpatientclinic. As aresultof
the shorter waiting time, GPs could prescribe
symptomatic treatment rather than acid
suppression therapy, which may mask upper
gastrointestinalpathology, givingafalsenegative
endoscopy result. This may also reduce
unnecessary prescriptions for acid suppression
therapy with resulting economic benefits. In
addition, a rapid diagnosis may improve the
prognosis, forexample,inoesophagealcarcinoma
since earlier treatment can be instituted. Such an
improvement inprognosishas notbeenobserved
for early gastric cancer.3
Since its introduction in the 1970s open access
endoscopy has been surrounded by controversy
over its benefits. The referral system is open to
overuse by GPs and to counteract this some
centres censor the referrals and are not strictly
"open access".4 For example, a barium swallow
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examination may be more appropriate than
endoscopy as an initial investigation for certain
groups ofpatients withdysphagia.S Criticisms of
the open access service include the fact that
patients may be more anxious about their
procedurethanpatients screened at anoutpatient
clinicalthoughonerecentstudyhasnotconfirmed
this.6 In another study, 64% ofpatients preferred
to be seen at the consultant clinic first.7 There is
also a significant increase in workload for the
endoscopyunitbyprovidingsuchaservicedespite
a relatively low diagnostic yield.8
In order to succeed, centres offering an open
access service must be continually assessed and
monitored to ensure that their aims are being
achieved. We reviewed all OGDs performed in
the first year in which an open access endoscopy
service was offered to general practitioners Gps
inthe area surrounding Craigavon AreaHospital
in order to compare OGDs performed under the
open access service (OAE) and those referred
within thehospital (HR) to detectifthere are any
differences in waiting time, previous treatment,
symptomatology and endoscopic findings.
METHODS
AllOGDsperformedinCraigavonAreaHospital
between 1st April 1995 and 30th March 1996
were identified from computerised records. This
is adistrict general hospital serving apopulation
of200,000. Areviewofmedicalrecordswasthen
carriedouttakingnoteofthedemographicdetails,
waiting time from referral to OGD, symptoms
and smoking habits, therapy before OGD,
previousinvestigations, endoscopicfindingsand,
followingtheOGD,whetherfurtherinvestigations
were requested or if specific therapy was
suggested. A normal endoscopy was taken to be
the absence of pathology and included hiatus
hernia without oesophagitis. Where two or more
diagnoses were evident, the principal diagnosis
affecting treatment was used as the "endoscopic
finding". Thewaitingtimewastakentooriginate
from the date on which the open access referral
request form was sentby the GP for OAE, or the
clinic date on which it was decided to proceed to
OGD, in the HR group. A comparison was then
madebetweenopenaccessendoscopiesandthose
referred from hospital outpatient clinics to
determine if there were differences in referral
patterns, waitingtimesorthepathologicallesions
detected.
A standard OAE referral form with a list of ten
symptomsandaspacefortheappropriateresponse
was issuedto GPs. Demographic details, alcohol
and smoking habits were recorded. Guidelines
were issuedto GPs before commencement ofthe
OAE service. These indicated that patients over
45 years old presenting with a new onset of
dyspepsia and all patients with other sinister
symptoms (anaemia, dysphagia, weight loss,
family history of gastric neoplasia) should be
referredtoanoutpatientclinicinthefirstinstance.
All follow-up OGDs performed for surveillance
ofbenign ormalignant lesions were excluded. A
small number of emergency OGDs performed
each year in the hospital theatres for overt upper
gastrointestinal bleeding were not included. In
addition, OGDs performed as part of a limited
endoscopy service in arural hospital in the same
trust were also excluded.
STATISTICAL ANALYSIS
Statistics where appropriate are shown as mean
values with standard deviation in parentheses.
Groupcomparisonsofvariablesweremadeusing
the Chi-square test. Continuous variables were
compared using the Mann Whitney U-test. A
value ofp< 0.05 was considered significant.
RESULTS
Patients and waiting times
Seven hundred and ninety-two OGDs were
performed during the study period. Forty- one
were excluded since they were follow-up OGDs
and 12 medical records could not be obtained
leaving 739 in the group underconsideration. Of
these, 384 (177 male; mean age 48.0 yrs.) were
performed under open access referrals, 346 (149
male; mean age 50.7 yrs.) were referred from
hospital outpatient clinics and nine could not be
accurately classified.
The number of patients referred to the open
access systemdidnotdiffersignificantlybetween
fundholders and non-fundholders (111 v 273;
p=0.32). The mean waiting time in the OAE
group was 24.5 days (standard deviation 16.0;
range 1-119 days), compared to 29.8 days
(standard deviation 21; range 1-141 days) in the
HR group (p<0.001). The waiting time for
fundholders and non-fundholders was similar in
theHRgroup(29.0v30.1 days,p=0.43) although
fundholders had a longer wait for OAE (27.8 v
23.1 days, p=0.016).
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Clinicalfeatures and smoking habits
Theclinicalfeaturespresentineachofthegroups
are given in fig. 1. More patients in the OAE
group complained of epigastric pain (p=0.002),
nausea (p<0.001), heartburn (p<0.001) and
anorexia(p<0.001)thanintheHRgroup,whereas
more patients in the HR group had evidence of
gastrointestinal bleeding (p=0.003) and anaemia
(p<0.001) compared to the OAE group. The
prevalenceofvomiting,weightlossanddysphagia
did not differ between the two groups.
More patients with upper gastrointestinal
pathology (n=527) had anaemia compared to
those who had a normal OGD (n=203) (24 v 3;
p=0.046). Heartburn (49 v 85; p=0.022),
dysphagia(12 v 14; p=0.047) andweightloss (10
v 8; p=0.023) were more frequent inpatients with
oesophagitiscomparedtothenormalOGDgroup.
Therewas nodifferenceinthefrequency ofthese
featuresinpatientswithduodenalulcer/duodenitis
or gastric ulcer/gastritis compared to the normal
OGD group.
Asmokinghistorywas absentin314(82%)inthe
OAE group and 240 (69%) in the HR group
(p<0.001). Of those cases in which a smoking
history was given, the number of smokers was
similar in each group (41 v 53; p=O.17).
Treatment before OGD
Two hundred and ninety-five (77%) patients in
the OAE group were currently on upper
gastrointestinal treatment at the time of their
procedure compared to 186 (54%) in the HR
group(p<0.001). MorepatientsintheOAEgroup
were on proton pump inhibitors (134/384 v 90/
346; p=0.01) and H2 receptor antagonists (107/
384 v 74/346; p=0.048) compared to the HR
group. The number of patients referred to OAE
from fundholding practices on acid suppression
was similar to those from non-fundholding
practices(78/111 v 163/273;p=0.062). However,
more patients in the fundholding group were on
proton pump inhibitors (48/111 v 86/273,
p=0.034); nodifferencewasobservedforpatients
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on H2 receptor antagonists (30/111 v 77/273;
p=O.9).
Previous investigations
Previousuppergastrointestinalinvestigationshad
been carried out in 175 (45%) in the OAE group
compared to 198 (57%) in the HR group
(p=0.002). There were 81 OGDs (32 v 49,
p=0.019), 115 ultrasound abdominal
examinations (45 v 70, p=0.002 and 258 barium
meal examinations (134 v 124, p=0.82).
Endoscopyfindings
OGD findings are shown infig. 2. There were no
significant differences between the two groups.
In particular, the number of oesophageal (1 v 3)
and gastric tumours (2 v 2) was similar in each
group. All patients with upper gastrointestinal
tumours were over 65 years.
Helicobacterpylori (HP) testing by CLO test (a
rapid urease test for campylobacter-like
organisms) testwasperformedin 162intheOAE
group, of whom 81 (50%) were positive and 74
(91%) of these were prescribed eradication
therapy. Of 118 CLO tests in the HR group, 58
(50%)werepositiveand54(93%)wereprescribed
eradication therapy. Of 185 patients prescribed
eradication therapy, 51 (28%) had duodenal
ulcers, 64 (35%) had duodenitis, 34 (18%) had
gastritis and nine were normal.
Follow-up investigations
Furtherinvestigations wererequestedin54ofthe
OAE group compared to 37 in the HR group
(p=0.1). These included abdominal ultrasound
examination (n=53), 24-hour pH monitoring
(n=15) and barium meal examinations (n=7).
Bariummeals(n=7)wereperformedtoinvestigate
the upper gastrointestinal tract further. In 2 of
these further information was gained which had
notbeendetectedonOGD(bothduodenalulcers).
Therapeutic guidelines
Specific therapy was suggested in 245 (64%) in
theOAEgroupcomparedto 240(69%) intheHR
group (p=O.14). No therapeutic guidelines were
Figure 2: A comparison of the endoscopy findings in the Open Access and
Hospital-referred OGD groups (DU = duodenal ulcer; NG = neoplasm)
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given in the letterto the GPin 187 cases (94 v 93,
p=0.55) and "symptomatic therapy" was
suggested in 56 cases (43 v 13, p<0.001).
DISCUSSION
Open access endoscopy has been the subject of
much controversy since its initiation over 20
years ago. Our study clearly demonstrates that
thereis asignificantreductioninwaitingtimefor
OAE compared to HR endoscopy. There was no
significant difference in waiting time for
fundholders and non-fundholders for HR
endoscopy, although fundholders had a longer
waiting time for OAE. The waiting time for HR
endoscopy does nottakeinto accountthe waiting
time to be seen at the outpatient clinic which
obviously varies widely forthe three consultants
offeringthis service andadds tothewaitingtime.
Theextentofpre-treatmentwithacidsuppression
therapy in both groups is a cause for concern
since this may lead to healing of pathological
lesions prior to endoscopy, it may cause a false-
negative Helicobacter pylori result9 and it may
also delay the diagnosis ofearly gastric cancer.10
Acid suppression therapy was more prevalent in
the OAE than the HR group, both for proton
pump inhibitors and H2receptorantagonists, and
thisdifferencemayreflectGPsprescribinghabits.
It is clear that there is extensive use of proton
pump inhibitors before endoscopy whichis more
prevalent in fundholding than non- fundholding
practices. For fundholding practices, empirical
acid suppression therapy may be perceived as a
more economical option although clearly these
patients mayneedtoproceedtoendoscopyforan
accurate diagnosis ifempirical treatment fails to
relieve symptoms. A waiting time of24 days for
open access endoscopy should enable GPs to
prescribe symptomatic treatment only before
endoscopy since there are benefits to the patient
from a reliable, accurate diagnosis.
As expected, more patients in the HR group had
anaemia and upper GI bleeding compared to the
OAE group, whereas less sinister features of
epigastric pain, heartburn, anorexia and nausea
were more prevalent in the OAE group. One
possible explanation for this is that the OAE
referral form has a list of ten symptoms with a
space for the appropriate response, whereas
symptoms in the HR group rely on an adequate
and thorough history being taken by the doctor.
Thisintroduces aninevitablebiaswithatendency
for increased reporting of symptoms in the OAE
group.Regardingthemajoruppergastrointestinal
pathologies, more patients with oesophagitis
reported three symptoms (heartburn, dysphagia,
weightloss)comparedtothenormal OGDgroup.
Although heartburn is more common in the
oesophagitis group it has a poor specificity as it
is reported in42% (n=85) ofthose with anormal
OGD. This underlines that symptoms are
generallyapoorpredictorofuppergastrointestinal
pathologyemphasisingtheusefulness ofOGDin
the evaluation of patients with dyspeptic
symptoms.1 The absence ofa smoking history, in
particular, on the OAE form which involves a
"circle as appropriate" response is clearly
inadequate in view of the significance that this
may have on upper gastrointestinal pathology
and Helicobacterpylori infection.
Our finding that previous investigations were
more common in the HR group clearly indicates
that upper gastrointestinal symptoms and
pathology are often recurrent leading to hospital
referral or re-referral and investigation. This
introduces an inevitable selection bias in the HR
group which cannot be avoided.
Theyieldofpositiveendoscopicfindingsbetween
OAE and HR did not differ significantly which
contrasts with a previous study which has found
thatspecialists haveahigheryieldofinformation
relevanttopatientcare.1IZuccaroetalalsofound
that gastroenterologists have a more appropriate
use of OAE (85 v 81%) and a higher percentage
of positive endoscopic findings (62 v 52%)
compared to non-gastroenterology internists.'2
We found that specific therapeutic guidelines
weregiveninapproximatelytwo-thirdsofpatients
inbothgroups whereas "symptomatictreatment"
was suggestedinasmallnumberofcases. Clearly
therapeutic advice post-OGD is at the discretion
of the endoscopist and is entirely arbitrary. It is
apparent that the level of specific therapeutic
advice given to GPs under both forms of
endoscopy referral is similar.
OAEhas amajorimpactonpatients' management
inprimary careandanormalendoscopy canhave
as much value as an abnormal one although it is
hard to quantify this. Benefits to the patients are
a rationalisation of medication, reduced
consultations,lowerhospitalreferralrates,"Imore
rapiddiagnosis ofbenign disease and morerapid
reassuranceofpatientsconcernedaboutneoplasia,
whichisaconcernwith41%t ofpatients.'13Despite
the fact that the number ofupper gastrointestinal
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tumourswassmall,thiswassimilarinbothgroups
and a restriction on OAE cannot be justified at
present, onthis basis, since individual symptoms
have a poor discriminant value."3 However,
targeting the service to those over 45 years old
couldreduce the numberofprocedures, increase
thediagnosticyieldandstilldetectallthetumours
in our patients.
Recently strategies have been proposed for non-
invasive screening for Helicobacter pylori in
dyspeptics under 45 years. H.pylori positive
subjectscaneitherbegivenempiricaleradication
orundergo OGD.14,15 Heaney etalhave reported
that H.pylori negative subjects can be treated
symptomatically, without undergoing OGD due
to the low rate of pathology, thus reducing
endoscopy workload by 42% and resulting in
improvements in dyspepsia and quality oflife at
6-month follow-up.15 This strategy has been
proposedtoimproveselectionofyoungdyspeptic
patients for endoscopy and clearly reduces the
workload of the endoscopy unit.
During its first year, the OAE service provided
more rapid diagnosis forpatients referred to this
service, although the diagnostic yield including
uppergastrointestinaltumourswassimilar,when
compared to the HR group. Further follow-up is
required to ensure that the shorter waiting time
for OAE is maintained over subsequent years.
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